Gastric corpus IL-8 concentration and neutrophil infiltration in duodenal ulcer patients

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 4, 1997, Pages 793-800

  Uemura, N ^a   Oomoto, Y ^b   Mukai, T ^a   Okamoto, S ^a   Yamaguchi, S ^a   Mashiba, H ^a   Taniyama, K ^a   Sasaki, N ^a   Sumii, K ^c   Haruma, K ^c   Kajiyama, G ^c  

^a Kure Kyosai Hospital   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CELL INFILTRATION; CLINICAL ARTICLE; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; NEUTROPHIL; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA;

EID: 8544274470     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00218.x     Document Type: Article

References (28)

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983: i: 1275-5.
2. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992: 102: 720-7.
3. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from prospective investigation. Br Med J 1991; 302: 1302-5.
4. Parsonnet J, Friedman GD, Daniel MS, et al. Helicobacter pylori infection and the risk of gastric carcinoma. New Engl J Med 1991: 325: 1127-31.
5. Nomura A, Stemmermann GN, Chyouph Kato I, Perez-Perz GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. New Engl J Med 1991; 325: 1132-6.
6. Fujioka T, Shuto R, Kodama R, Kubota T, Nasu M. Experimental model for chronic gastritis with Helicobacter pylori: Long-term follow-up study in H. pylori infected Japanese macaques. Eur J Gastroenterol Hepatol 1993; 5(Suppl. 1): S73-5.
7. Correa P. Chronic gastritis. In: Whitehead R, ed. Gastrointestinal and Oesophageal Pathology. London: Churchill Livingstone, 1989; 402-20.
8. Sipponen P, Kekki M, Siurala M. The Sydney System: epidemiology and natural history of chronic gastritis. J Gastroenterol Hepatol 1991; 6: 244-51.
9. Crabtree JE, Covacci A, Farmery SM, et al. Helicobacter pylori induced interleukin-8 expression in gastric epithelium cells is associated with CagA positive phenotype. J Clin Pathol 1995; 48: 41-5.
10. Peek RM, Miller GG, Tham KT, et al. Heightened cytokine expression and inflammatory response in vivo to cagA+ Helicobacter pylori and strains. Gastoenterology 1995; 108: A189(Abstract).
11. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-5.
12. Sugiyama T, Furuyama S, Awakawa T. Local immune response of the gastric mucosa to Helicobacter pylori infection with and without intestinal metaplasia. Eur J Gastroenterol Hepatol 1993; 5: 199-202.
13. Matsushima K, Baldwin ET, Mukaida N. Interleukin-8 and MCAF. Novel leukocyte recruitment and activating cytokines. Chem Immunol 1992; 51: 236-65.
14. Crabtree JE, Peichl P, Wyatt JI, Stachl U, Lindley IJD. Gastric IL-8 and IL-8 IgA autoantibodies in Helicobacter pylori infection. Scand J Immunol 1993; 37: 65-70.
15. Gionchetti P, Vaira D, Campieri M, et al. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol 1994; 89: 883-7.
16. Peterson GL. A simplication of the protein assay method of Lowly et al. which is more generally applicable. Anal Biochem 1987; 83: 346-56.
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis - the updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
18. Marks IN, Shay H. Observations on the pathogenesis of gastric ulcer. Lancet 1959; i: 1107-11.
19. Louw JA, Falck V, van Rensberg C. Distribution of Helicobacter pylori colonization and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcer. J Clin Pathol 1993; 46: 754-6.
20. Solcia E, Villani L, Fiocca R, Lazzaroni M, Bianchi Porro G. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994; 29(Suppl. 201): 28-34.
21. Schrger J, Spink R, Mitra S. The antrum in patients with duodenal and gastric ulcer. Gut 1967; 8: 497-508.
22. Stolte M, Eidt S, Ohsman A. Difference in expression of Helicobacter pylori in the antrum and body of the stomach. Z Gastroenterol 1992; 28: 229-33.
23. Logan RPH, Walker MM, Misiewicz JJ, et al. Changes in the intra gastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 12-6.
24. Solcia E, Fiocca R, Villani L, Carlsson J, Rudback A, Zeijlon L. Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics. Scand J Gastroenterol 1996; 31 (Suppl. 215): 105-10.
25. Lee A, Dixon MF, Danon SJ, et al. Local acid production and Helicobacter pylori: A unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol 1995; 7: 461-5.
26. Kuipers EJ, Uyterlide AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: Implications for long-term safety. Am J Gastroenterol 1995; 90: 1401-6.
27. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagilis treated with omeprazole or fundoplication. New Engl J Med 1996; 334: 1018-22.
28. Burnstein M, Monge E, Leon BR, Lozano R, Berendoson R, Gilman RH. Low peptic ulcer and high gastric cancer prevalence in developing country with a high prevalence of infection by Helicobacter pylori. J Clin Gastroenterol 1991; 13: 154-6.